News

Interim data indicates that in all nine of the BMN 190 patients who have been followed for at least six months and up to 15 months, the treatment

The research agreement will identify targets for this therapy in myelodysplastic syndrome (MDS), a bone marrow disorder in which the body does not produce sufficient healthy blood cells.

DUOPA is administered using a small, portable infusion pump that delivers carbidopa and levodopa directly into the small intestine for 16 continuous hours via a procedurally-placed tube. DUOPA

Under the five-year deal, Perrigo will have exclusivity on a full line of store brand gummy vitamin, mineral and supplement products using Ferrara’s gummy technology and manufacturing capabilities.

Alirocumab is an investigational monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9 (PCSK9). The marketing application is based on data from more than 5,000 patients, including ten Phase

The deal will see development of new treatments using Omnis’ cancer-killing virus technology and later sell them if they seem to be successful. In the project, key agents

As part of the deal, Adimab will build a new custom library and transfer it to GSK for its internal use in the discovery of bispecifics. The new

The collaboration will further advance FMI’s position in molecular information and genomic analysis while providing Roche an opportunity to optimize the identification and development of new treatment options

Established in 2012, Melanovus obtained an exclusive global license from the Penn State Research Foundation to a library of compounds and related intellectual property. These compounds originate from